Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.41
(-1.22%)
HKD 0.41
(-1.22%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 405.09 Million CNY | 74.98% |
| 2022 | 231.5 Million CNY | 655.9% |
| 2021 | 30.62 Million CNY | 122.94% |
| 2020 | -133.53 Million CNY | -35.21% |
| 2019 | -98.76 Million CNY | -115.71% |
| 2018 | -45.78 Million CNY | -146.23% |
| 2017 | -18.59 Million CNY | 10.24% |
| 2016 | -20.71 Million CNY | -257.73% |
| 2015 | -5.79 Million CNY | -120.47% |
| 2014 | 28.29 Million CNY | -29.63% |
| 2013 | 40.21 Million CNY | 10.84% |
| 2012 | 36.27 Million CNY | -69.09% |
| 2011 | 117.36 Million CNY | 96.1% |
| 2010 | 59.85 Million CNY | 11.1% |
| 2009 | 53.86 Million CNY | -33.79% |
| 2008 | 81.36 Million CNY | -35.83% |
| 2007 | 126.78 Million CNY | 24.85% |
| 2006 | 101.55 Million CNY | 48.7% |
| 2005 | 68.29 Million CNY | 290.88% |
| 2004 | -35.77 Million CNY | 60.63% |
| 2003 | -90.87 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 470.7 Million CNY | 0.38% |
| 2024 Q1 | 470.7 Million CNY | 16.2% |
| 2023 Q3 | 404.13 Million CNY | 28.25% |
| 2023 FY | 405.09 Million CNY | 74.98% |
| 2023 Q4 | 405.09 Million CNY | 0.24% |
| 2023 Q1 | 314.74 Million CNY | 35.95% |
| 2023 Q2 | 315.12 Million CNY | 0.12% |
| 2022 Q1 | 130.55 Million CNY | 326.27% |
| 2022 Q2 | 131.15 Million CNY | 0.46% |
| 2022 Q3 | 230.82 Million CNY | 76.0% |
| 2022 FY | 231.5 Million CNY | 655.9% |
| 2022 Q4 | 231.5 Million CNY | 0.29% |
| 2021 Q2 | 12.07 Million CNY | 0.0% |
| 2021 FY | 30.62 Million CNY | 122.94% |
| 2021 Q1 | 12.07 Million CNY | 109.04% |
| 2021 Q3 | 30.04 Million CNY | 148.82% |
| 2021 Q4 | 30.62 Million CNY | 1.94% |
| 2020 Q2 | -106.56 Million CNY | 0.61% |
| 2020 Q3 | -133.84 Million CNY | -25.6% |
| 2020 Q4 | -133.53 Million CNY | 0.23% |
| 2020 Q1 | -107.21 Million CNY | -8.56% |
| 2020 FY | -133.53 Million CNY | -35.21% |
| 2019 Q3 | -99.4 Million CNY | -3.5% |
| 2019 Q2 | -96.04 Million CNY | 0.0% |
| 2019 Q4 | -98.76 Million CNY | 0.64% |
| 2019 FY | -98.76 Million CNY | -115.71% |
| 2019 Q1 | -96.04 Million CNY | -109.76% |
| 2018 Q4 | -45.78 Million CNY | 0.0% |
| 2018 Q2 | -37.5 Million CNY | 0.0% |
| 2018 FY | -45.78 Million CNY | -146.23% |
| 2018 Q1 | -37.5 Million CNY | -101.69% |
| 2018 Q3 | -45.78 Million CNY | -22.08% |
| 2017 Q3 | -18.59 Million CNY | -14.47% |
| 2017 Q4 | -18.59 Million CNY | 0.0% |
| 2017 FY | -18.59 Million CNY | 10.24% |
| 2017 Q1 | -16.24 Million CNY | 21.59% |
| 2017 Q2 | -16.24 Million CNY | 0.0% |
| 2016 Q3 | -20.71 Million CNY | -49.92% |
| 2016 FY | -20.71 Million CNY | -257.73% |
| 2016 Q4 | -20.71 Million CNY | 0.0% |
| 2016 Q2 | -13.81 Million CNY | 0.0% |
| 2016 Q1 | -13.81 Million CNY | -138.61% |
| 2015 Q4 | -5.79 Million CNY | 0.0% |
| 2015 Q1 | 1.97 Million CNY | -93.01% |
| 2015 FY | -5.79 Million CNY | -120.47% |
| 2015 Q2 | 1.97 Million CNY | 0.0% |
| 2015 Q3 | -5.79 Million CNY | -392.92% |
| 2014 Q4 | 28.29 Million CNY | 0.0% |
| 2014 Q3 | 28.29 Million CNY | -7.12% |
| 2014 Q2 | 30.46 Million CNY | 0.0% |
| 2014 Q1 | 30.46 Million CNY | -24.24% |
| 2014 FY | 28.29 Million CNY | -29.63% |
| 2013 Q2 | 34.14 Million CNY | -68.59% |
| 2013 Q3 | 40.21 Million CNY | 17.78% |
| 2013 Q4 | 40.21 Million CNY | 0.0% |
| 2013 FY | 40.21 Million CNY | 10.84% |
| 2013 Q1 | 108.68 Million CNY | 199.59% |
| 2012 FY | 36.27 Million CNY | -69.09% |
| 2012 Q3 | 67.33 Million CNY | -35.41% |
| 2012 Q4 | 36.27 Million CNY | -46.12% |
| 2012 Q2 | 104.24 Million CNY | 0.0% |
| 2011 FY | 117.36 Million CNY | 96.1% |
| 2011 Q2 | 77.65 Million CNY | 0.0% |
| 2011 Q4 | 117.36 Million CNY | 0.0% |
| 2010 Q2 | 63.2 Million CNY | 0.0% |
| 2010 FY | 59.85 Million CNY | 11.1% |
| 2010 Q4 | 59.85 Million CNY | 0.0% |
| 2009 FY | 53.86 Million CNY | -33.79% |
| 2008 FY | 81.36 Million CNY | -35.83% |
| 2007 FY | 126.78 Million CNY | 24.85% |
| 2006 FY | 101.55 Million CNY | 48.7% |
| 2005 FY | 68.29 Million CNY | 290.88% |
| 2004 FY | -35.77 Million CNY | 60.63% |
| 2003 FY | -90.87 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 128.02 Million HKD | -216.42% |
| Lee & Man Chemical Company Limited | 415.24 Million HKD | 2.446% |